Additionally, weight loss occurs across the body and can’t be directed to one area. The best approach to reducing belly fat is adopting healthy eating and exercise habits to support sustainable ...

Weight-loss drug users may find themselves having to scale back. The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound ...

When it comes to weight loss, providers and patients argue that GLP-1 medications are not a one-for-one swap and that volatile insurance coverage contradicts the science and experience of people ...

CVS's Caremark PBM made Wegovy its preferred weight-loss drug offering starting July 1. It said the move reflected lower pricing from Novo that it hopes will help add health plan clients for whom ...

The company reported obesity sales of 5.7 billion Danish crowns ($895 million) in 2019 from Saxenda, a far less effective weight-loss drug. In 2024, obesity sales had already reached 65.1 billion ...

JBS SA said demand for meat is benefiting from an unlikely source: weight-loss drugs. People on GLP-1 medication seem to be adding more protein to their diets, further increasing demand for ...

GLP-1 weight-loss drugs such as Wegovy and Zepbound have taken the health care world by storm, with hundreds of thousands of people turning to the medications for their pound-shedding properties.

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some analysts see a need for the online website to adjust to changing ...